AG000DMO

117048-59-6 | Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-

Chemical structure of Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, CAS 117048-59-6
AG000DMO
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 117048-59-6
Catalog Number AG000DMO(AGN-PC-0NZ6CE)
Chemical Name Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-
IUPAC Name 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol
InChI InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5-
InChI Key HVXBOLULGPECHP-WAYWQWQTSA-N
MDL Number MFCD03453309
Molecular Formula C18H20O5
Molecular Weight 316.3484
NSC Number 613729
SMILES O(C)C1=C(OC)C=C(/C=C\C2=CC(O)=C(OC)C=C2)C=C1OC
UNII 16U6OP69RQ
Synonyms
1-(3,4,5-trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenyl dihydrogen phosphate, 3,4,5-trimethoxy-3'-hydroxy-4'-methoxystilbene, CA4DP, combretastatin A-4, combretastatin A-4 disodium phosphate, combretastatin A4, combretastatin A4 phosphate, CRC 87-09, CRC-98-09, deoxycombretastatin A-4, fosbretabulin, isocombretastatin A-4, NSC 817373, NSC-817373, phenol, 2-methoxy-5-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-,1-(dihydrogen phosphate), phenol, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, dihydrogen phosphate, Combretastatin A4, 117048-59-6, Combretastatin A-4, Combretastatin-A4, Crc 87-09, UNII-16U6OP69RQ, NSC 817373, Combrestatin A4, (Z)-2-METHOXY-5-(3,4,5-TRIMETHOXYSTYRYL)PHENOL, CHEMBL67, NSC-613729, 16U6OP69RQ, HVXBOLULGPECHP-WAYWQWQTSA-N, MFCD03453309, CA-4, Crc-98-09, 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol, 3,4,5-Trimethoxy-3'-hydroxy-4'-methoxystilbene, 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol, 2-Methoxy-5-[(Z)-2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol, NSC 609397, NSC 613729, 1-(3,4,5-Trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene, Phenol, 2-methoxy-5-(2-(3,4,5-trimethoxyphenyl)ethenyl)-, (Z)-, Phenol, 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]-, (Z)-, combretastin A4, Combrestatin A-4, Combretastin A-4, AK128410, CA4, Combretastastin A-4, 2-methoxy-5-(3,4,5-trimethoxystyryl)phenol, Z-Combretastatin A-4, AC1NS0CC, 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenol, 2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol, CS-A4, SCHEMBL18945, combretastatin A-4, (CSA4), Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, CA 4, GTPL8854, PHE021, AOB1953, HMS3650G11, ACT02766, HY-N2146, BDBM50005480, BG0511, s7783, ZINC13452167, AKOS015950727, AC-5280, ACN-028881, CS-6023, DS-5860, MCULE-9118029221, Phenol,4,5-trimethoxyphenyl)ethenyl]-, RL00638, ST-1986, AJ-63828, BC226031, SC-96865, AB0073032, AB1003973, AX8017677, ST2401963, ST4149439, TL8000482, B6764, Combretastatin A4, >=98% (HPLC), powder, Y0443, 5-(3,4,5-trimethoxystyryl)-2-methoxyphenol, A12601, C20268, 3'-Hydroxy-3,4,4',5-tetramethoxy-cis-stilbene, (Z)-5-(3,4,5-trimethoxystyryl)-2-methoxyphenol, 048C596, SR-01000946784, (Z)-3''-hydroxy-3,4,4'',5-tetramethoxystilbene, SR-01000946784-1, [3,4,5-trimethoxy-3'-hydroxy-4'-methoxy-(z)-stilbene], 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)vinyl]phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol, 5-[(1Z)-2-(3,4,5-trimethoxyphenyl)vinyl]-2-methoxyphenol, 2-Methoxy-5-[(Z)-2-(3,4,5-trimethox y-phenyl)-vinyl]-phenol, 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)-1-ethenyl]phenol, (combretastin A-4)2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol, (combretastatin A-4)2-Methoxy-5-[2-(3,4,5-trimethoxy-phenyl)-vinyl]-phenol, (Z)-2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenol, 3,4,5-Trimethoxy-3 inverted exclamation mark -hydroxy-4 inverted exclamation mark -methoxy-(Z)-stilbene, 1-(3,4,5-Trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl) ethane 3,4,5-trimethoxy-3'-hydroxy-4'-methoxystilbene, 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol; CA4; 1-(3,4,5-Trimethoxyphenyl)-2-(3 inverted exclamation marka-hydroxy-4 inverted exclamation marka-methoxyphenyl) ethane 3,4,5-trimethoxy-3 inverted exclamation marka-hydroxy-4 inverted exclamation marka-methoxystilbene, Combretastatin, Fosbretabulin, (-)-Combretastatin, isocombretastatin A-4, deoxycombretastatin A-4, CA4DP, (Z)-Combretastatin A4, combretastatin A4 phosphate, cc-322, C18H20O5, NSC613729, combretastatin A-4 disodium phosphate, C18-H20-O5, CID5351344, NSC-817373, Combretastatin A-4, 98% - 25MG 25mg, C2520, C058728, 5-[(S)-2-Hydroxy-2-(3,4,5-trimethoxy-phenyl)-ethyl]-2-methoxy-phenol, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenyl dihydrogen phosphate, phenol, 2-methoxy-5-((1z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-,1-(dihydrogen phosphate), phenol, 2-methoxy-5-((z)-2-(3,4,5-trimethoxyphenyl)ethenyl)-, dihydrogen phosphate,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited